Venous thromboembolism and the pill. The combined oral contraceptive pill - Are poor communication systems responsible for loss of confidence in this contraceptive method?

Human Reproduction

Volumn 14, Issue 1, 1999, Pages 7-10

  Mills, Angela ^a   Edwards, I Ralph ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ABORTION; DRUG INDUSTRY; DRUG MONITORING; DRUG SAFETY; GOVERNMENT; HEALTH CARE MANAGEMENT; HUMAN; MASS COMMUNICATION; MEDICAL DECISION MAKING; MORTALITY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PUBLIC HEALTH SERVICE; RISK BENEFIT ANALYSIS; SHORT SURVEY; THROMBOEMBOLISM; PATIENT ATTITUDE; PATIENT EDUCATION; REVIEW; RISK FACTOR;

CONTRACEPTIVES, ORAL, COMBINED; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; RISK FACTORS;

EID: 0032906077     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.1.7     Document Type: Short Survey

References (22)

1. Anonymous (1997) The media magnified the false alarm about the pill; abortions increased in Sweden. Journalisten. 30th January 1997.
2. Benagiano, G. (1998) Learning from the past: venous thromboembolism and the pill: an endless saga. Hum. Reprod., 13, 1115-1116.
3. Bloemenkamp, K.W.M., Rosendaal, F.R., Helmerhorst, F.M. et al. (1995) Enhancement of factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third generation progestogen, Lancet, 346, 1593-1596.
4. Committee on Safety of Medicines (1995) Combined oral Contraceptives and Thromboembolism. Letter 17 October 1995. Committee on Safety of Medicines, London, UK.
5. Edwards, I.R. (1997) Who cares about pharmacovigilance? Eur. J. Clin. Pharm., 53, 83-88.
6. Edwards, I.R and Hugman, B. (1997) The challenge of effective benefit-risk information communication. Drug Safety, 17, 216-227.
7. Edwards, I.R., Wilholm, B. and Martinez, C. (1996) Concepts in benefit-risk assessment a simple merit analysis of a medicine? Drug Safety, 15, 1-7.
8. Edwards, R.G., Beard, H.K. and Bradshaw, J.P. (1997) Balancing the risks and benefits of oral contraception. [Editorial.] Hum. Reprod., 12, 2339-2340.
9. Erice Declaration (1997) HYPERLINK http://www.who.pharmasoft.se/ communications.htm http://www.who.pharmasoft.se/communications.htm
10. Hannaford, P.C. and Owen-Smith V. (1998) Using epidemiological data to guide clinical practice: review of studies on cardiovascular disease and use of combined oral contraceptives. Br. Med. J., 316, 984-987.
11. HMSO (1996) Confidential Enquiries into Maternal Deaths in the United Kingdom, 1991-1993. HMSO, London, UK.
12. Jick, H., Jick, S., Gurewich, V. et al. (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet, 346, 1589-1593.
13. Lancet (1997) Time to act to avoid drug scares. [Editorial] Lancet, 350, 1041.
14. McNamee, D. (1997) Communicating drug safety information. Lancet, 350, 1646.
15. Mills, A. (1997) Combined oral contraception and the risk of venous thromboembolism. Hum. Reprod., 12, 2595-2598.
16. Mills, A.M., Wilkinson, C.L., Bromham, D.R. et al. (1996) Guidelines for prescribing the combined oral contraceptives. Br. Med. J., 312, 121-122.
17. Office for National Statistics (1997) ONS Monitor AB 97. London, UK.
18. Skejeldestad, F.E. (1997) Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.Contraception, 55, 11-14.
19. Spitzer, W.O. (1997) The 1995 pill scare revisited: anatomy of a non-epidemic. Hum. Reprod., 12, 2347-2357.
20. Spitzer, W.O., Lewis, M., Heinemann, L.A.J. et al. (1996) on behalf of the Transnational Research Group on oral contraceptives and the health of young women. Third generation oral contraceptives and risk. Br. Med. J., 312, 83-88.
21. Vessey, M.P. (1989) The Jeffcott lecture: An overview of the benefits and risks of combined oral contraceptives. In Mann, R.D. (ed.). Oral Contraceptives and Breast Cancer: The Implications of the Present Findings for Informed Consent and Informed Choice. Parthenon Publishing Group, New Jersey, USA, pp. 121-135.
22. World Health Organization (1995) Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestogens in low dose oral contraceptives on venous thromboembolic disease. Lancet, 346, 1582-1588.